Displaying 1 - 20 of 35 tests
T&B Tissue Flow Panel
Stand-alone test. Markers are CD2, CD3, CD4, CD5, CD7, CD8, CD10, CD11c, CD19, CD20, CD23, CD34, CD38, CD45, CD56, kappa, and lambda (17 markers).
Flow Cytometry
T-ALL Add-On Flow Panel
Available as global and tech-only. This add-on panel is available to clarify findings on samples currently having flow cytometry analysis at NeoGenomics and is not available for stand-alone testing. Markers are CD1a, CD3, CD7, CD11b, CD19, CD43, CD45, cMPO, and nTdT (9 markers).
Flow Cytometry
T-ALL Follow-Up Flow Panel
Available as global and tech-only. Please provide clinical history including the time after treatment. Prior immunophenotyping at NeoGenomics with Standard or Extended Flow Panel is strongly recommended. Clients who decline full phenotyping and order a global or push-to-global Follow-Up Panel are
Flow Cytometry
T-Cell Lymphoma Follow-Up Flow Panel
Available as global and tech-only. Please provide clinical history including the time after treatment. Prior immunophenotyping at NeoGenomics with Standard or Extended Flow Panel is strongly recommended. Clients who decline full phenotyping and order a global or push-to-global Follow-Up Panel are
Flow Cytometry
T-Cell Receptor Beta Gene Rearrangement
This test provides qualitative detection of monoclonal T-cell receptor (TCR) beta gene rearrangements by PCR and fragment analysis according to BIOMED-2 consensus primer design. This test may be ordered concurrently with or after negative results in our T-Cell Receptor Gamma Gene Rearrangement assay
Molecular
T-Cell Receptor Gamma Gene Rearrangement
Detection of clonal T-cell receptor gamma (TCRG) gene rearrangements by PCR of variable and joining regions. T-Cell Receptor Beta Gene Rearrangement is offered separately and may be added to this gamma gene test.
Molecular
T-Cell Receptor/LGL Add-On Flow Panel
Available as global and tech-only. This add-on panel is available to clarify findings on samples currently having flow cytometry analysis at NeoGenomics and is not available for stand-alone testing. Markers are CD3, CD4, CD7, CD8, CD16, CD45, CD56, CD57, TCR alpha/beta, and TCR gamma/delta (10
Flow Cytometry
T-Cell Therapy Flow Panel
Available as global and tech-only. Available as stand-alone test (as described here) or as add-on to panels. Markers are CD3, CD4, CD7, CD8, CD25, CD26, CD30, CD45, CD52, and CD279 (10 markers).
Flow Cytometry
Tau
Tau is important in establishing and maintaining neuronal morphology and is a major component of the neurofibrillary tangles (NFTs) characteristic of an Alzheimer's diseased brain. Tau is also expressed in epithelial cells, including breast tissue. Down-regulation of Tau expression in breast cancer
Immunohistochemistry (IHC)
TCL1
Probes: TCL1 (14q32.1) Disease(s): mature T-cell leukemia, T-cell prolymphocytic leukemia (T-PLL), adult T-cell leukemia/lymphoma (ATLL)
FISH
TCL1
T-cell leukemia/lymphoma protein 1 (TCL1) is normally found in the nucleus and cytoplasm of lymphoid lineage cells during early embryogenesis. Chromosomal translocations may lead to overexpression of TCL1, resulting in T-cell leukemia and B-cell lymphoma. TCL1 is expressed in more differentiated B
Immunohistochemistry (IHC)
TCRβF1
T Cell Receptor beta (TCRβ) is used as a phenotypic marker for TCRβ expressing T-cells. TCRβ is expressed by thymocytes and a majority of peripheral (α/β TCR-bearing) T-cells. This antibody does not cross-react with γ/Δ TCR-bearing T-cells.
Immunohistochemistry (IHC)
TdT (Terminal Deoxynucleotidyl Transferase)
TdT is a highly specific marker for the diagnosis and classification of acute lymphoblastic lymphoma/leukemias. The determination of TdT expression is most valuable when it is important to differentiate histologically between lymphoblastic lymphoma and Burkitt lymphoma.
Immunohistochemistry (IHC)
TERT Promoter Mutation Analysis
Bi-directional Sanger sequencing is performed using PCR primers designed to target mutations in the promoter region of TERT.
Molecular
TET2 Mutation Analysis
Bi-directional sequencing of the entire coding sequence of the TET2 transcript variant A (2002 amino acids in length).
Molecular
TFE3
Overexpression of TFE3 is a sensitive and specific marker of Xp11 translocation in renal cell carcinomas. TFE3 is also expressed in alveolar soft part sarcoma the hallmark of which is a chromosomal rearrangement at 17q25 and Xp11.2 engendering an ASPSCR1–TFE3 fusion gene. Use of this antibody is an
Immunohistochemistry (IHC)
TGF Alpha (Transforming Growth Factor Alpha)
Transforming growth factor (TGF)-α is a polypeptide growth factor that binds to the epidermal growth factor receptor and is thought to stimulate cell proliferation. TGF-α is expressed in several non-neoplastic tissues and in a variety of tumors. It plays a role in tumor progression via the
Immunohistochemistry (IHC)
Thrombomodulin (TM)
Thrombomodulin (TM) is a plasma membrane-related glycoprotein that has anticoagulant activity. TM antigen is found in several cell types, including megakaryocytes, mesangial cells, synovial cells, mesothelial cells, endothelial cells, and some squamous epithelial cells and their associated tumors.
Immunohistochemistry (IHC)
Thyroglobulin (TGB)
This antibody labels thyroglobulin (TGB) in follicular epithelial cells of the thyroid and colloid. Thyroglobulin antibody is useful in positive identification of thyroid carcinomas of the papillary and follicular types. Demonstration of thyroglobulin in a metastatic lesion establishes the thyroid
Immunohistochemistry (IHC)
TIA1
TIA1 (T-cell intracytoplasmic antigen) monoclonal antibody reacts with a 15 kDa cytoplasmic granule-associated protein, expressed in lymphocytes processing cytolytic potential. Most anaplastic large cell lymphomas react with TIA1. TIA1 also reacts with most large granular lymphocytic leukemias,
Immunohistochemistry (IHC)